Leukemia Research

Mutations of the ras genes in childhood acute myeloid leukemia, myelodysplastic syndrome and juvenile chronic myelocytic leukemia
pp. 697-701(5)
Authors: Minami S.; Mura-e R.; Okamoto Y.; Sanekata T.; Matsuhashi A.; Tanioka S.; Shigemasa Y.; Xiao M.S.; Kawamura M.; Ohnishi H.; Ida K.; Hanada R.; Kojima S.; Kobayashi M.; Bessho F.; Yanagisawa M.; Hayashi Y.

Amplified C-MYC sequences localized by fluorescence in-situ hybridization on double minute chromosomes in acute myeloid leukemias
pp. 703-709(7)
Authors: Fugazza G.; Bruzzone R.; Puppo L.; Patrone F.; Sessarego M.

NF-M trans-activates the human DNA topoisomerase II promoter independently of C-MYB in HL-60 cells
pp. 711-720(10)
Authors: Naimi M.; Gessner F.B.; Okamoto Y.; Southwood L.; Stashak T.S.; Norrdin R.W.; Nelson A.W.; Minami S.; Matsuhashi A.; Kato K.; Shigemasa Y.; Brandt T.L.; Kroll D.J.

Exon 5 mutations in the p53 gene in relapsed childhood acute lymphoblastic leukemia
pp. 721-729(9)
Authors: Blau O.; Avigad S.; Stark B.; Kodman Y.; Luria D.; Cohen I.J.; Zaizov R.

Ca²⁺/Mg²⁺-dependent endonuclease in marrow CD34 positive and erythroid cells in myelodysplasia
pp. 731-734(4)
Authors: Chakroun W.M.; Medhin M.W.; Taylor R.P.; Bianchi E.; Marsano E.; Ricco L.; Conio G.; Anzai N.; Kawabata H.; Hishita T.; Yoshida Y.; Ueda Y.; Okuma M.

Granulocyte-colony stimulating factor induces differentiation and apoptosis of CD2, CD7 positive hybrid leukemia cells in vivo and ex vivo
pp. 735-741(7)
Authors: Fujiwara H.; Arima N.; Matsushita K.; Hidaka S.; Ohtsubo H.; Fukumori J.; Arimura K.; Kukita T.; Tanaka H.

The MRD1 (p-glycoprotein) and MRP (P-190) transporters do not play a major role in the intrinsic multiple drug resistance of jurkat T lymphocytes
pp. 743-752(10)
Authors: Noda T.; Takahata Y.; Sato T.; Ikoma H.; Mochida H.; Martel J.; Payet M.D.; Dupuis G.

The effect of cytokines, including IL4, IL7, stem cell factor, insulin-like growth factor on childhood acute lymphoblastic leukemia
pp. 753-761(9)
Authors: Ariff A.B.; Asbi B.A.; Azudin M.N.; Kennedy J.F.; Consolini R.; Legitimo A.; Cattani M.; Simi P.; Mattii L.; Petrini M.; Putti C.; Basso G.

T-stem cell leukemia/lymphoma with both myeloid lineage conversion and T-specific recombination
pp. 763-773(11)
Authors: Yang S.-A.; Hsu C.-H.; Hingorani S.; Rao M.A.; Okechukwu P.E.; Da Silva P.M.S.; Oliveira J.C.; Nagano M.; Kimura N.; Akiyoshi T.; Nishimura J.; Kozuru M.; Okamura J.; Katsuno M.; Yoshida T.; Takeshita M.; Tachibana K.; Ohshima K.; Kikuchi M.

Quality of life in young patients with chronic myelocytic leukaemia during intensive treatment including interferon
pp. 775-783(9)
Authors: Bohlander M.; Qi W.; Ellis P.R.; Ross-Murphy S.B.; Burchard W.; Stalfelt A.M.; Zettervall O.

How important is hepatitis C virus (HCV)-infection in persons with acute leukemia?
pp. 785-788(4)
Authors: Kyungsoo W.; Seib P.A.; Ribas A.; Butturini A.; Locasciulli A.; Arico M.; Gale R.P.

Effect of short-course high-dose methylprednisolone treatment on serum IL-2 levels in children with myelodysplastic syndromes: a pilot study
pp. 789-791(3)
Authors: How T.; Takechi K.; Furuhata K.-i.; Yenicesu I.; Hicsonmez G.; Tuncer A.M.

MLL rearrangements in infant leukemia: is there a higher frequency in females?
pp. 793-795(3)
Authors: Yan X.; Saniei N.; Bresolin T.M.B.; Sander P.C.; Reicher F.; Sierakowski M.R.; Rinaudo M.; Ganter J.L.M.S.; Ross J.A.; Robison L.L.